Corneal Ectasia Clinical Trial
Official title:
Corneal Topographic Changes in Different Grades of Obstructive Sleep Apnea Syndrome
Corneal topographic parameters in different degrees of obstructive sleep apnea
Obstructive sleep apnea (OSA) syndrome is a disease characterized by recurrent total or partial upper airway collapse during sleep, interrupting or reducing the airflow, and after ward resulting in temporary awakening which causes restoration of flow of the upper airway. These intermittent complete (apnea) or partial (hypopnea) respiratory cessations decrease blood oxygen levels (hypoxia). Upper airway stenosis causes hypoxemia and hypercapnia, which can lead to multiple organ dysfunction and is associated with systemic diseases, such as hypertension, diabetes, and coronary arteriosclerosis, and changes in the eyes include floppy eyelid syndrome, keratoconus, and glaucoma. The prevalence of OSA is between 2% and 10% in females and 4-20% in males and obesity is a major risk factor for the development of OSA. With all the adverse effects associated with OSA, its secondary effects cause several ocular complications. Previous studies have shown that OSA is associated with increased risks of several vision-threatening and nonthreatening ocular disorders, including senile cataracts, normal-tension glaucoma, retinal ischemia, conjunctival hyperemia, and dry eye. Several contributory mechanisms to the ocular complications of OSA have been reported, including intermittent hypoxia, oxidative stress, systemic inflammatory responses (such as interleukin-6 (IL-6), IL-8, tumor necrosis factor-alpha (TNF-α), C-Reactive protein (CRP), matrix metalloproteinase 9 (MMP-9), vascular cell adhesion molecule (VCAM), intercellular adhesion molecule (ICAM), selectins), sympathetic system overaction, damage effects of endothelin-1, and disruption of the blood-retinal barrier (BRB) (6-8). There are limited publications that manipulate the corneal topographic parameters in different degrees of OSA, especially in the Egyptian population. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03319082 -
Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery
|
||
Recruiting |
NCT02009709 -
Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2
|
Phase 1 | |
Recruiting |
NCT04094090 -
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
|
Phase 2 | |
Completed |
NCT04405882 -
Cornea Ectasia Excimer Laser Treatment
|
||
Active, not recruiting |
NCT01464268 -
Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia
|
Phase 3 | |
Active, not recruiting |
NCT04763785 -
Development of a Keratoconus Detection Algorithm by Deep Learning Analysis and Its Validation on Eyestar Images
|
||
Recruiting |
NCT01325298 -
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
|
Phase 2 | |
Recruiting |
NCT04251143 -
Dresden Corneal Disease and Treatment Study
|
||
Active, not recruiting |
NCT01152541 -
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
|
Phase 3 | |
Recruiting |
NCT04905108 -
Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia
|
Phase 3 | |
Recruiting |
NCT04401865 -
Safety and Effectiveness of the PXL-Platinum 330 System
|
Phase 1/Phase 2 | |
Completed |
NCT05691335 -
Three Different Cross-linking Protocols for Treatment of Pediatric Keratoconus
|
N/A | |
Completed |
NCT04475900 -
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
|
||
Recruiting |
NCT05027295 -
Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light
|
Phase 3 | |
Completed |
NCT03913338 -
Laser In-situ Keratomileusis With Crosslinking Compared to Conventional LASIK in Patients With High Myopia
|
N/A | |
Terminated |
NCT01459679 -
Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery
|
Phase 3 | |
Withdrawn |
NCT01643252 -
Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
|
Phase 3 | |
Active, not recruiting |
NCT04698590 -
Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism
|
N/A | |
Completed |
NCT04177082 -
Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
|
Phase 1 | |
Completed |
NCT06348368 -
Refractive and Corneal Topographic Characteristics in Upper Egypt Children With High Cylinder
|